BiomX Inc. (PHGE)
NYSEAMERICAN: PHGE · Real-Time Price · USD
2.070
-0.120 (-5.48%)
At close: Dec 23, 2025, 1:00 PM EST
2.020
-0.050 (-2.42%)
Pre-market: Dec 24, 2025, 8:35 AM EST
BiomX Market Cap
BiomX has a market cap or net worth of $3.16 million as of December 24, 2025. Its market cap has decreased by -73.13% in one year.
Market Cap
3.16M
Enterprise Value
2.82M
1-Year Change
-73.13%
Ranking
Category
Stock Price
$2.07
Market Cap Chart
Since July 17, 2019, BiomX's market cap has decreased from $1.93B to $3.16M, a decrease of -99.84%. That is a compound annual growth rate of -63.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 3.34M | -74.81% |
| Dec 31, 2024 | 13.27M | 3.09% |
| Dec 29, 2023 | 12.87M | 130.01% |
| Dec 30, 2022 | 5.60M | -87.59% |
| Dec 31, 2021 | 45.11M | -69.57% |
| Dec 31, 2020 | 148.28M | -32.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 958.53B |
| Johnson & Johnson | 494.99B |
| AbbVie | 404.18B |
| UnitedHealth Group | 294.11B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 260.22B |
| Novo Nordisk | 232.28B |